Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia

Among women diagnosed with stage I–IIIa, node-negative, hormone receptor (HR)-positive breast cancer (BC), Oncotype DX recurrence scores (ODX RS) inform chemotherapy treatment decisions. Differences in recurrence scores or testing may contribute to racial disparities in BC mortality among women with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:NPJ Breast Cancer
Main Authors: Collin, Lindsay J., Yan, Ming, Jiang, Renjian, Ward, Kevin C., Crawford, Brittany, Torres, Mylin A., Gogineni, Keerthi, Subhedar, Preeti D., Puvanesarajah, Samantha, Gaudet, Mia M., McCullough, Lauren E.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6763428/
https://ncbi.nlm.nih.gov/pubmed/31583272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0129-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados